New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 13, 2013
13:17 EDTVPHM, SNY, SHPG, GSViroPharma hires Goldman to explore sale, Bloomberg says
ViroPharma (VPHM) has hired Goldman Sachs (GS) to explore a sale after receiving takeover interest from Sanofi (SNY) and Shire (SHPG), reports Bloomberg, citing people with knowledge of the process. Shares of ViroPharma traded sharply higher following initial headlines of the report, and are currently up better than 25% in afternoon trade. U.S.-listed shares of Shire are off their worst levels and have turned positive following the report, while Sanofi shares are little changed. Reference Link
News For VPHM;SNY;SHPG;GS From The Last 14 Days
Check below for free stories on VPHM;SNY;SHPG;GS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 26, 2014
09:51 EDTGSOn The Fly: Analyst Initiation Summary
Cray (CRAY) initiated with a Buy at Stifel... Enphase Energy (ENPH) initiated with a Buy at Needham... FCB Financial (FCB) initiated with a Buy at UBS... FCB Financial initiated with an Overweight at JPMorgan... Goldman Sachs (GS) initiated with a Buy at MKM Partners... HealthEquity (HQY) initiated with a Neutral at RW Bair... Mobileye (MBLY) initiated with a Buy at Deutsche Bank... Mobileye initiated with a Neutral at Goldman... Mobileye initiated with a Neutral at RW Baird... Mobileye initiated with an Overweight at Barclays... RAIT Financial (RAS) initiated with an Outperform at JMP Securities... SunEdison (SUNE) initiated with an Outperform at FBR Capital... Mobileye initiated with an Outperform at Raymond James... Transocean Partners (RIG) initiated with an Overweight at Morgan Stanley... GT Advanced (GTAT) coverage resumed with an Overweight at Piper Jaffray... LinkedIn (LNKD) initiated with an Overweight at First Analysis... CSC (CSC) initiated with a Sector Perform at RBC Capital... United Natural Foods (UNFI) initiated with an Overweight at Stephens.
07:52 EDTGSGoldman developing rival messaging system to Bloomberg, NY Post says
Goldman Sachs is wary of Bloomberg’s ability to analyze data collected via its ubiquitous terminals and the bank is developing a cross-bank messaging and market data program, called Symphony, as a result, according to The New York Post. Reference Link
05:56 EDTGSGoldman Sachs initiated with a Buy at MKM Partners
Subscribe for More Information
August 25, 2014
12:19 EDTSNYOn The Fly: Midday Wrap
Subscribe for More Information
11:48 EDTSNYSanofi and Regeneron co-host a conference call
Subscribe for More Information
10:40 EDTSNYBiotechs rise after InterMune acquired by Roche
Subscribe for More Information
07:32 EDTGSGoldman likely to name small new-partner class for 2014, WSJ reports
Subscribe for More Information
August 24, 2014
21:23 EDTGSLender group set to offer EDMC revised debt package, NY Post says
Subscribe for More Information
16:56 EDTGSGoldman likely to limit partner designations this fall, WSJ says
Subscribe for More Information
August 22, 2014
17:18 EDTGSGoldman Sachs announces agreements with FHFA to repurchase $3.15B in RMBS
Subscribe for More Information
13:41 EDTGSGoldman Sachs near $1.1B payment to settle FHFA claims, FT reports
Subscribe for More Information
12:39 EDTSNYThese five companies will benefit from increased ALS awareness, MarketWatch says
A recent surge in funding for Lou Gehrig's disease, or ALS, caused by the Ice Bucket challenge that is widespread on social media outlets, will benefit five pharmaceutical companies that are involved in the development of a cure for ALS, according to MarketWatch. The companies that are or have been involved in developing a treatment for ALS include Biogen Idec (BIIB), Avanir Pharmaceuticals (AVNR), Isis Pharmaceuticals (ISIS), Sanofi (SNY), and Bristol-Myers Squibb (BMY), MarketWatch added. Reference Link
06:42 EDTGSBlackstone in discussions to back China-based fund, Bloomberg says
Blackstone (BX) is in discussions to possibly back Hong Kong-based distressed fund, Arkkan Capital Management, which was founded by the former global leader of Goldman Sachs' (GS) special situations division Jason Brown, according to Bloomberg, citing two people with knowledge of the matter. Reference Link
August 21, 2014
06:43 EDTGSRegulators up bank warning efforts for poor risk assessment, Reuters says
Subscribe for More Information
05:42 EDTSNYIllumina announces strategic partnership with AstraZeneca, Sanofi, Janssen
Illumina (ILMN) announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing, or NGS,-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine. Initial strategic partners include AstraZeneca (AZN), Janssen Biotech, a Johnson & Johnson (JNJ) company, and Sanofi (SNY). Illumina is working with the strategic partners to develop assays that detect and measure multiple variants simultaneously to support partners’ clinical trials, with the objectives of securing regulatory agency approvals and test commercialization. In parallel, Illumina is working with key thought leaders to set standards for NGS-based assays in routine clinical oncology practice, as well as to define regulatory frameworks to enable this new testing paradigm. Together, Illumina and its strategic partners aim to transition from single-analyte companion diagnostics to panel-based assays that select for “companion therapeutics.”
August 20, 2014
18:29 EDTGSBofA, JPMorgan weigh plans to raise salaries for junior bankers, Bloomberg says
Subscribe for More Information
11:37 EDTGSGoldman ups U.S. junior employees FY15 wages by 20%, Bloomberg says
Subscribe for More Information
10:32 EDTGSGoldman to up U.S. junior employees FY15 salaries by 20%, Bloomberg says
Subscribe for More Information
August 19, 2014
16:46 EDTSNYFDA approves Genzyme Cerdelga capsules
Subscribe for More Information
06:34 EDTGSGoldman abandons effort to toss out $1B Gaddafi suit, Telegraph says
Goldman Sachs (GS) abandoned its effort to toss out a London court suit from the Libyan Investment Authority who alleged that the bank lost over $1B worth of funds during the final years of Muammar Gaddafi's reign as dictator, according to the Telegraph, citing comments from the LIA. The LIA sued both Goldman and Societe Generale (SCGLY) over claims that the banks' London divisions took-in exorbitant fees while losing money in derivative trades. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use